Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Cash from Financing Activities came in at -$592000.0 in Q1 2026, down 104.32% year-on-year from $13.7 million in Q1 2025, and up 48.48% quarter-over-quarter from -$1.1 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$592000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 104.32% year-over-year to -$592000.0 in Q1 2026; TTM through Mar 2026 was -$9.2 million, a 78.29% decrease from a year earlier, with the FY2025 full-year figure at $5.1 million, up 125.09% from the prior year.
  • Cash from Financing Activities improved to -$592000.0 in Q1 2026 per AAWH's latest filing, from -$1.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $54.7 million in Q2 2022 and bottomed at -$14.0 million in Q2 2025.
  • The 5-year median for Cash from Financing Activities is -$1.1 million (2025), against an average of $2.3 million.
  • Across the five-year window, Cash from Financing Activities soared 1070.0% in 2022 and tumbled 6947.95% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $18.5 million in 2022, then sank by 99.61% to $73000.0 in 2023, then tumbled by 6947.95% to -$5.0 million in 2024, then jumped by 77.02% to -$1.1 million in 2025, then jumped by 48.48% to -$592000.0 in 2026.
  • Per Business Quant, the three latest AAWH Cash from Financing Activities figures stand at -$592000.0 (Q1 2026), -$1.1 million (Q4 2025), and $6.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn -592,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -592,000.00
Mar 31, 2026 -592,000.00
Dec 31, 2025 -1.15 Mn
Dec 31, 2025 -1.15 Mn
Sep 30, 2025 6.54 Mn
Sep 30, 2025 6.54 Mn
Jun 30, 2025 -13.98 Mn
Jun 30, 2025 -13.98 Mn
Mar 31, 2025 13.69 Mn
Mar 31, 2025 13.69 Mn
Dec 31, 2024 -5.00 Mn
Dec 31, 2024 -5.00 Mn
Sep 30, 2024 -9.27 Mn
Sep 30, 2024 -9.27 Mn
Jun 30, 2024 -4.57 Mn
Jun 30, 2024 -4.57 Mn
Mar 31, 2024 -1.52 Mn
Mar 31, 2024 -1.52 Mn
Dec 31, 2023 73,000.00
Dec 31, 2023 73,000.00